{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:07:42Z","timestamp":1779091662459,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Peroxisome biogenesis disorders (PBDs) are rare autosomal recessive neurodegenerative diseases caused by variants in Peroxin (\n                      <jats:italic>PEX)<\/jats:italic>\n                      genes, leading to defective peroxisome assembly and multisystem dysfunction. The\n                      <jats:italic>PEX12<\/jats:italic>\n                      variant NM_000286.3: c.1047_1049del (NP_000277.1: p.Gln349del) has been described almost exclusively in Egyptian patients, suggesting a founder effect. We present the first Egyptian case with this variant showing bilateral optic atrophy, expanding the known clinical phenotype of\n                      <jats:italic>PEX12<\/jats:italic>\n                      -related PBD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A six-year-old Egyptian boy, born to first-cousin parents, presented with early hypotonia, developmental regression, visual inattention, and sensorineural hearing loss. Early milestones were initially normal, followed by progressive motor and cognitive decline beginning at age three. Ophthalmologic examination revealed bilateral optic atrophy, and audiologic testing confirmed profound sensorineural hearing loss. Brain Magnetic Resonance Imaging (MRI) showed bilateral periventricular and cerebellar white matter hyperintensities, with restricted diffusion in the involved areas and corpus callosum involvement. Laboratory studies were unremarkable, but trio whole-exome sequencing identified a homozygous\n                      <jats:italic>PEX12<\/jats:italic>\n                      deletion (c.1047_1049del), confirming a diagnosis within the Zellweger spectrum of peroxisome biogenesis disorders. The patient was managed with supportive multidisciplinary care, including levetiracetam for seizure control, physiotherapy, nutritional support, and regular follow-up. At one-year follow-up, seizures were controlled, but severe neurological disability persisted.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This case highlights a rare\n                      <jats:italic>PEX12<\/jats:italic>\n                      -related peroxisome biogenesis disorder with optic atrophy\u2014an unreported feature of this variant\u2014broadening its phenotypic spectrum. It underscores the diagnostic value of whole-exome sequencing when biochemical tests are inconclusive and emphasizes the need for increased awareness of founder variants in populations with high consanguinity to enable earlier diagnosis, counseling, and targeted screening.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06931-2","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:04:59Z","timestamp":1779087899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early hypotonia and visual regression as presenting features of peroxisome biogenesis disorder: an Egyptian case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Abdelrahim A.","family":"Sadek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Aladawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek M. M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Naser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0883-3018","authenticated-orcid":false,"given":"Mohamed M.","family":"Elmoursy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6006-1227","authenticated-orcid":false,"given":"Sohieb","family":"Hedewy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hagag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawashty Ragab","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayed","family":"Abdelkreem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"6931_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","volume":"117","author":"NE Braverman","year":"2016","unstructured":"Braverman NE, Raymond GV, Rizzo WB, Moser AB, Wilkinson ME, Stone EM, et al. Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol Genet Metab. 2016;117:313\u201321. https:\/\/doi.org\/10.1016\/j.ymgme.2015.12.009.","journal-title":"Mol Genet Metab"},{"key":"6931_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00007611-198803000-00017","volume":"81","author":"H ZELLWEGER","year":"1988","unstructured":"ZELLWEGER H, MAERTENS P. History of the Cerebrohepatorenal Syndrome of Zellweger and Other Peroxisomal Disorders. South Med J. 1988;81:357\u201364. https:\/\/doi.org\/10.1097\/00007611-198803000-00017.","journal-title":"South Med J"},{"key":"6931_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.13107\/jocr.2250-0685.303","volume":"5","author":"Y Mahale","year":"2015","unstructured":"Mahale Y, Kadu VV, Chaudhari A. Rare Case of Rhizomelic Chondrodysplasia Punctata. J Orthop Case Rep. 2015;5:38\u201340. https:\/\/doi.org\/10.13107\/jocr.2250-0685.303.","journal-title":"J Orthop Case Rep"},{"key":"6931_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/jmedgenet-2012-100778","volume":"49","author":"MS Ebberink","year":"2012","unstructured":"Ebberink MS, Koster J, Visser G, van Spronsen F, Stolte-Dijkstra I, Smit GPA, et al. A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11\u03b2 gene. J Med Genet. 2012;49:307\u201313. https:\/\/doi.org\/10.1136\/jmedgenet-2012-100778.","journal-title":"J Med Genet"},{"key":"6931_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/humu.21388","volume":"32","author":"MS Ebberink","year":"2011","unstructured":"Ebberink MS, Mooijer PAW, Gootjes J, Koster J, Wanders RJA, Waterham HR. Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Hum Mutat. 2011;32:59\u201369. https:\/\/doi.org\/10.1002\/humu.21388.","journal-title":"Hum Mutat"},{"key":"6931_CR6","doi-asserted-by":"publisher","first-page":"e28539","DOI":"10.1371\/journal.pone.0028539","volume":"6","author":"P Brites","year":"2011","unstructured":"Brites P, Ferreira AS, Ferreira da Silva T, Sousa VF, Malheiro AR, Duran M, et al. Alkyl-Glycerol Rescues Plasmalogen Levels and Pathology of Ether-Phospholipid Deficient Mice. PLoS ONE. 2011;6:e28539. https:\/\/doi.org\/10.1371\/journal.pone.0028539.","journal-title":"PLoS ONE"},{"key":"6931_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ymgme.2004.08.008","volume":"83","author":"S Steinberg","year":"2004","unstructured":"Steinberg S, Chen L, Wei L, Moser A, Moser H, Cutting G, et al. The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. Mol Genet Metab. 2004;83:252\u201363. https:\/\/doi.org\/10.1016\/j.ymgme.2004.08.008.","journal-title":"Mol Genet Metab"},{"key":"6931_CR8","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s10072-020-04843-2","volume":"42","author":"MS Zaki","year":"2021","unstructured":"Zaki MS, Issa MY, Thomas MM, Elbendary HM, Rafat K, Al Menabawy NM, et al. A founder mutation in PEX12 among Egyptian patients in peroxisomal biogenesis disorder. Neurol Sci. 2021;42:2737\u201345. https:\/\/doi.org\/10.1007\/s10072-020-04843-2.","journal-title":"Neurol Sci"},{"key":"6931_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.ejhg.5201090","volume":"12","author":"J Gootjes","year":"2004","unstructured":"Gootjes J, Schmohl F, Waterham HR, Wanders RJA. Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder. Eur J Hum Genet. 2004;12:115\u201320. https:\/\/doi.org\/10.1038\/sj.ejhg.5201090.","journal-title":"Eur J Hum Genet"},{"key":"6931_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10038-007-0157-y","volume":"52","author":"A Zeharia","year":"2007","unstructured":"Zeharia A, Ebberink MS, Wanders RJA, Waterham HR, Gutman A, Nissenkorn A, et al. A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40\u00b0C. J Hum Genet. 2007;52:599\u2013606. https:\/\/doi.org\/10.1007\/s10038-007-0157-y.","journal-title":"J Hum Genet"},{"key":"6931_CR11","unstructured":"Steinberg SJ, Raymond GV, Braverman NE, Moser AB. Zellweger Spectrum Disorder. 1993."},{"key":"6931_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s44162-022-00004-5","volume":"1","author":"G Temaj","year":"2022","unstructured":"Temaj G, Nuhii N, Sayer JA. The impact of consanguinity on human health and disease with an emphasis on rare diseases. J Rare Dis. 2022;1:2. https:\/\/doi.org\/10.1007\/s44162-022-00004-5.","journal-title":"J Rare Dis"},{"key":"6931_CR13","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","volume":"1863","author":"HR Waterham","year":"2016","unstructured":"Waterham HR, Ferdinandusse S, Wanders RJA. Human disorders of peroxisome metabolism and biogenesis. Biochimica et Biophysica Acta (BBA) -. Mol Cell Res. 2016;1863:922\u201333. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.11.015.","journal-title":"Mol Cell Res"},{"key":"6931_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jmg.2009.074302","volume":"47","author":"MS Ebberink","year":"2010","unstructured":"Ebberink MS, Csanyi B, Chong WK, Denis S, Sharp P, Mooijer PAW, et al. Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene. J Med Genet. 2010;47:608\u201315. https:\/\/doi.org\/10.1136\/jmg.2009.074302.","journal-title":"J Med Genet"},{"key":"6931_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10545-015-9880-2","volume":"39","author":"K Berendse","year":"2016","unstructured":"Berendse K, Engelen M, Ferdinandusse S, Majoie CBLM, Waterham HR, Vaz FM, et al. Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood. J Inherit Metab Dis. 2016;39:93\u2013106. https:\/\/doi.org\/10.1007\/s10545-015-9880-2.","journal-title":"J Inherit Metab Dis"},{"key":"6931_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.22035","volume":"68","author":"L R\u00e9gal","year":"2010","unstructured":"R\u00e9gal L, Ebberink MS, Goemans N, Wanders RJA, De Meirleir L, Jaeken J, et al. Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol. 2010;68:259\u201363. https:\/\/doi.org\/10.1002\/ana.22035.","journal-title":"Ann Neurol"},{"key":"6931_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1212\/01.wnl.0000106943.40848.03","volume":"62","author":"PG Barth","year":"2004","unstructured":"Barth PG, Majoie CBLM, Gootjes J, Wanders RJA, Waterham HR, van der Knaap MS, et al. Neuroimaging of peroxisome biogenesis disorders (Zellweger spectrum) with prolonged survival. Neurology. 2004;62:439\u201344. https:\/\/doi.org\/10.1212\/01.wnl.0000106943.40848.03.","journal-title":"Neurology"},{"key":"6931_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13023-015-0368-9","volume":"10","author":"FCC Klouwer","year":"2015","unstructured":"Klouwer FCC, Berendse K, Ferdinandusse S, Wanders RJA, Engelen M, Poll-The BT. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis. 2015;10:151. https:\/\/doi.org\/10.1186\/s13023-015-0368-9.","journal-title":"Orphanet J Rare Dis"},{"key":"6931_CR19","doi-asserted-by":"publisher","first-page":"982564","DOI":"10.3389\/fcell.2022.982564","volume":"10","author":"CT Chen","year":"2022","unstructured":"Chen CT, Shao Z, Fu Z. Dysfunctional peroxisomal lipid metabolisms and their ocular manifestations. Front Cell Dev Biol. 2022;10:982564. https:\/\/doi.org\/10.3389\/fcell.2022.982564.","journal-title":"Front Cell Dev Biol"},{"key":"6931_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0039-6257(91)90185-I","volume":"35","author":"SJ Folz","year":"1991","unstructured":"Folz SJ, Trobe JD. The peroxisome and the eye. Surv Ophthalmol. 1991;35:353\u201368. https:\/\/doi.org\/10.1016\/0039-6257(91)90185-I.","journal-title":"Surv Ophthalmol"},{"key":"6931_CR21","unstructured":"Elumalai V, Pasrija D. Zellweger Spectrum Disorder. 2025."},{"key":"6931_CR22","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.bbadis.2012.06.004","volume":"1822","author":"Y Fujiki","year":"2012","unstructured":"Fujiki Y, Yagita Y, Matsuzaki T. Peroxisome biogenesis disorders: Molecular basis for impaired peroxisomal membrane assembly. Biochim et Biophys Acta (BBA) - Mol Basis Disease. 2012;1822:1337\u201342. https:\/\/doi.org\/10.1016\/j.bbadis.2012.06.004.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Basis Disease"},{"key":"6931_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.biochem.74.082803.133329","volume":"75","author":"RJA Wanders","year":"2006","unstructured":"Wanders RJA, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem. 2006;75:295\u2013332. https:\/\/doi.org\/10.1146\/annurev.biochem.74.082803.133329.","journal-title":"Annu Rev Biochem"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06931-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06931-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06931-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:31:10Z","timestamp":1779089470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06931-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6931"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06931-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this case report was obtained from the Institutional Review Board (IRB) of the Faculty of Medicine, Al-Azhar University, Assiut, Egypt (Approval Code: RESEARCH\/AZ.AST.\/PED025\/9\/237\/11\/2024; Approval Date: 14 November 2024). Written informed consent was obtained from the patient\u2019s parents for participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this case report, including any identifiable clinical data and images, was obtained from the patient\u2019s parents. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}